University of Arizona Cancer Center
The University of Arizona Cancer Center is an NCI-designated Comprehensive Cancer Center in Tucson, Arizona, delivering multidisciplinary cancer treatment, 200+ clinical trials, and translational research across multiple Arizona locations to patients, providers, and industry collaborators.
- Company typePrivate
- Founded1976
- HeadquartersTucson, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What University of Arizona Cancer Center does
The University of Arizona Cancer Center (UACC) is an NCI-designated Comprehensive Cancer Center headquartered in Tucson, Arizona, and the only such center headquartered in the state. Founded in 1976 and operating as part of the University of Arizona, the center delivers multidisciplinary cancer care across 14 disease-specific clinical research teams spanning BMT/Leukemia, Breast, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Lymphoma/Myeloma, Melanoma/Cutaneous, Pediatric, Phase 1, Prevention, Radiation Oncology, Sarcoma, and Thoracic (Lung) cancers. It runs more than 200 active clinical trials and operates multiple clinical locations across Arizona including a Phoenix research presence, supporting patient enrollment through its Arizona Clinical Trials Network.
On the research side, UACC organizes work around three established scientific programs — Cancer Biology, Cancer Prevention & Control, and Clinical and Translational Oncology — across more than 70 research laboratories staffed by 700+ doctors, scientists, postdoctoral fellows, graduate students, and technicians. Proprietary technology platforms include the Molecular Twin Precision Oncology Platform (MT-POP), an AI-based multi-omic approach to personalized treatment prediction developed by director Dr. Dan Theodorescu, the COXEN algorithm (validated in the SWOG 1314 national trial), first-in-class RalGTPase inhibitor IP in commercial development, and organoid-based experimental platforms. Shared resource cores include Analytical Chemistry, Biostatistics & Bioinformatics, Flow Cytometry, Microscopy, and others. Sub-brands include the Ginny L. Clements Breast Cancer Institute, the Skin Cancer Institute, and the Convergent Science Virtual Cancer Center (CSVCC).
Revenue is generated through a hybrid model combining clinical services (variable pricing, insurance-based), federal and state research grants (NCI Cancer Center Support Grant, R35, SPORE, and other NIH mechanisms), philanthropy and endowments (including a $1 million Duval Endowed Professorship gift), and industry-sponsored research agreements (e.g., investigator-sponsored trials with biotech/pharma). Go-to-market is sales-led via physician referrals, clinical trial recruitment, community outreach, and direct patient engagement across Arizona and the broader Southwest region. The center does not publicly disclose consolidated revenue figures.
University of Arizona Cancer Center firmographics
Firmographics- Name
- University of Arizona Cancer Center
- Legal name
- University of Arizona Cancer Center
- Website
- https://cancercenter.arizona.edu
- Company type
- Private
- Founded year
- 1976
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- The University of Arizona Cancer Center is an NCI-designated Comprehensive Cancer Center in Tucson, Arizona, delivering multidisciplinary cancer treatment, 200+ clinical trials, and translational research across multiple Arizona locations to patients, providers, and industry collaborators.
- Ownership category
- akta.pro rank
University of Arizona Cancer Center industry classification
Industry- Product category
- Comprehensive Cancer Center / Oncology Healthcare Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Other Health Practitioners (6213)
- SIC
- Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro industry
- Medical OncologyOncology & Cancer Specialty HospitalsHealthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty CareRadiation OncologyGastrointestinal Oncology
Keywords
Where University of Arizona Cancer Center is headquartered
LocationHeadquarters
- HQ city
- Tucson
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
University of Arizona Cancer Center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Clinical Services Revenue: Revenue generated from patient care services across multiple clinical locations in Arizona including treatment, diagnostics, and support services
- Federal and State Research Grants: NCI Cancer Center Support Grant (CCSG), R35 Outstanding Investigator Award, SPORE grants, and other federal research funding
- Philanthropy and Endowments: Private donations, endowment income, and charitable giving such as the $1 million John F. and Valli S. Duval Endowed Professorship gift
- Industry Sponsored Research: Collaborative research agreements with pharmaceutical companies and biotech firms including investigator-sponsored trials
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Patient care services with variable pricing based on treatment type and insurance coverage |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
University of Arizona Cancer Center product offering
Product offeringCore offering
The University of Arizona Cancer Center is an NCI-designated Comprehensive Cancer Center providing cancer treatment, clinical trials, and translational research across 14 disease-specific clinical research teams (including breast, gastrointestinal, genitourinary, lung, hematologic, pediatric, and melanoma cancers). It integrates patient care, basic research, and population science through three research programs (Cancer Biology, Cancer Prevention & Control, Clinical and Translational Oncology), supported by 70+ research laboratories and 200+ active clinical trials. Patient services include multidisciplinary care teams, integrative oncology programs (yoga, nutrition, spirituality), and survivorship support.
Product overview
The University of Arizona Cancer Center is a single unified healthcare institution providing comprehensive cancer care services. It operates as an NCI-designated Comprehensive Cancer Center offering treatment across 14 disease-specific clinical research teams (BMT/Leukemia, Breast Cancer, GI, GU, Gynecologic, Head and Neck, Lymphoma/Myeloma, Melanoma, Pediatric, Phase 1, Prevention, Radiation Oncology, Sarcoma, Thoracic). The Center integrates research and clinical care through three research programs (Cancer Biology, Cancer Prevention & Control, Clinical and Translational Oncology), dedicated institutes for Breast Cancer (Ginny L. Clements) and Skin Cancer, the Convergent Science Virtual Cancer Center for cross-disciplinary research, and shared resource core facilities. Patient support includes Holistic Circles of Care offering integrative oncology services. The institution is engaged in more than 200 clinical trials.
Differentiator
Problem solved
Functional benefit
Brands
- Ginny L. Clements Breast Cancer Institute: Dedicated breast cancer research and treatment institute within the cancer center
- Skin Cancer Institute
Products and services
- University of Arizona Cancer Center (Comprehensive Cancer Care) NCI-designated Comprehensive Cancer Center providing multidisciplinary cancer treatment and care across 14 disease-specific clinical research teams (BMT/Leukemia, Breast, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Lymphoma/Myeloma, Melanoma/Cutaneous, Pediatric, Phase 1, Prevention, Radiation Oncology, Sarcoma, Thoracic/Lung) for patients in Arizona and the Southwest.
- Clinical Trials Program More than 200 active clinical trials investigating new diagnostic, prevention, and treatment strategies across multiple cancer types, available for patient enrollment through the cancer center and the Arizona Clinical Trials Network.
- Research Programs Three established scientific research programs (Cancer Biology, Cancer Prevention & Control, Clinical and Translational Oncology) conducted across 70+ research laboratories, supporting basic, translational, and population science cancer research.
- Shared Resources (Core Facilities) Core facilities supporting cancer research, including Analytical Chemistry, Behavioral Measurement and Interventions, Biospecimen Services, Biostatistics & Bioinformatics, Experimental Mouse, Flow Cytometry Immune Monitoring, Microscopy, and Tissue Acquisition and Cellular/Molecular Analysis.
- Arizona Clinical Trials Network Statewide network facilitating cancer clinical trial participation across Arizona, expanding patient access to investigational therapies.
- Holistic Circles of Care Integrative oncology services for cancer patients including yoga, spirituality programming, nutrition during cancer treatment, and support groups and integrative medicine programs.
- Ginny L. Clements Breast Cancer Institute Dedicated breast cancer institute focused on breast cancer research, prevention, and treatment within the University of Arizona Cancer Center.
- Skin Cancer Institute
Quantifiable outcome
- 200+ clinical trials available for patient enrollment
- +2 more outcomes
Companies that use University of Arizona Cancer Center
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
University of Arizona Cancer Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
University of Arizona Cancer Center partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, flagship and minor.
- Tucson Fire DepartmentcoreCollaborative cancer prevention trial testing broccoli-derived dietary supplement (Avmacol) to help firefighters process harmful chemical exposures from fires and mitigate cancer risk associated with firefighting chemical exposures. Early-stage clinical trial conducted with Tucson Fire Department.
- Fennec PharmaceuticalscoreInvestigator-sponsored Phase I/II study evaluating PEDMARK (sodium thiosulfate injection) for reducing hearing impairment caused by cisplatin chemotherapy in adolescent, young adult, and adult patients with head and neck and testicular cancers.
- Association of American Cancer Institutes (AACI)coreDr. Joann Sweasy serves as AACI president, leading national Rural Cancer Summit initiative and campaign to address rural cancer disparities across U.S. and Canada.
- National Cancer InstituteflagshipNCI-designated Comprehensive Cancer Center with Cancer Center Support Grant (CCSG) funding, representing the only NCI comprehensive designation in Arizona.
- International Myeloma FoundationminorSponsorship of Multiple Myeloma support groups, providing patient education and support services for blood cancer patients and families.
- Pascua Yaqui Tribe Health DepartmentcoreCo-hosting Beyond Cancer conference focused on cancer care and survivorship for tribal communities, demonstrating commitment to Native American health disparities.
- Banner HealthcorePartnership for oncology support groups and patient services, including hybrid support groups for various cancer types at Banner facilities.
- Arizona Center for Drug DiscoverycoreCo-hosting 7th Annual Drug Discovery and Development Summit showcasing translational cancer research from bench to bedside, sponsored by College of Medicine - Phoenix, R. Ken Coit College of Pharmacy, and Cancer Center.
Scale indicators5 records
Expansion highlights6 records
University of Arizona Cancer Center competitors and assessment
Company assessmentDirect peers
- Mayo Clinic Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center with multi-site clinical operations and integrated research programs; directly comparable to UACC in comprehensive designation and disease-team model.
- City of Hope Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center with extensive clinical trial portfolio and translational research; comparable to UACC on NCI designation and integrated research-clinical model.
- Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai: NCI-designated Comprehensive Cancer Institute previously led by UACC Director Dr. Theodorescu (2018–2025); directly comparable as an NCI-designated center with strong translational research portfolio.
- Fred Hutchinson Cancer Center: NCI-designated Comprehensive Cancer Center with leading translational science, bone marrow transplant program, and prevention research; directly comparable on NCI designation and BMT/Leukemia specialty programs.
- Dana-Farber Cancer Institute: NCI-designated Comprehensive Cancer Center affiliated with Harvard Medical School; comparable in translational research depth, clinical trial volume, and specialty oncology programs.
- MD Anderson Cancer Center: Largest NCI-designated Comprehensive Cancer Center in the U.S. Direct peer in NCI designation tier, multi-disease oncology clinical programs, and industry-sponsored trial pipeline.
- Memorial Sloan Kettering Cancer Center: Elite NCI-designated Comprehensive Cancer Center with deep translational research programs and 14+ disease-specific teams; direct peer on NCI designation, research scale, and clinical-trial portfolio.
- Winship Cancer Institute of Emory University: NCI-designated Comprehensive Cancer Center in a mid-size academic medical system; comparable in scale, NCI comprehensive designation, and disease-team clinical model.
- University of Colorado Cancer Center: NCI-designated Comprehensive Cancer Center previously led by UACC Director Dr. Dan Theodorescu (2010–2018); directly comparable in NCI designation tier, research program structure, and academic-medical-center operating model.
- UCSF Helen Diller Family Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center with comparable academic-medical-center structure, translational research programs, and clinical trial infrastructure.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
University of Arizona Cancer Center social profiles
Digital presenceUniversity of Arizona Cancer Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
University of Arizona Cancer Center leadership team
Management profileNumber of profiles
Profiles2 records
University of Arizona Cancer Center subsidiaries and ownership
Company hierarchySubsidiaries2 records
University of Arizona Cancer Center funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
University of Arizona Cancer Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about University of Arizona Cancer Center
What does University of Arizona Cancer Center do?
The University of Arizona Cancer Center is an NCI-designated Comprehensive Cancer Center providing cancer treatment, clinical trials, and translational research across 14 disease-specific clinical research teams (including breast, gastrointestinal, genitourinary, lung, hematologic, pediatric, and melanoma cancers). It integrates patient care, basic research, and population science through three research programs (Cancer Biology, Cancer Prevention & Control, Clinical and Translational Oncology), supported by 70+ research laboratories and 200+ active clinical trials. Patient services include multidisciplinary care teams, integrative oncology programs (yoga, nutrition, spirituality), and survivorship support.
Is University of Arizona Cancer Center a public or private company?
University of Arizona Cancer Center is a private company. It is classified as state government owned and is currently operating.
When was University of Arizona Cancer Center founded?
University of Arizona Cancer Center was founded in 1976. It employs 101 to 250 people.
Where is University of Arizona Cancer Center based?
University of Arizona Cancer Center is headquartered in Tucson, United States, in the North America region.
How does University of Arizona Cancer Center make money?
Four revenue lines are on record. Clinical Services Revenue is the primary driver. The others are federal and State Research Grants, philanthropy and Endowments and industry Sponsored Research.
Who are University of Arizona Cancer Center's main competitors?
Direct peers on record are Mayo Clinic Comprehensive Cancer Center, City of Hope Comprehensive Cancer Center, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai, Fred Hutchinson Cancer Center, Dana-Farber Cancer Institute, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Winship Cancer Institute of Emory University, University of Colorado Cancer Center and UCSF Helen Diller Family Comprehensive Cancer Center.
Does University of Arizona Cancer Center have an API?
No public API is recorded for University of Arizona Cancer Center.
What industry is University of Arizona Cancer Center in?
University of Arizona Cancer Center's product category is Comprehensive Cancer Center / Oncology Healthcare Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 622310 and its SIC code is 8060.